The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort
Abstract
BACKGROUND: The use fixed-dose combination (FDC) is a critical tool in improving HAART. Studies on the effectiveness of combined lamivudine, stavudine and nevirapine (3TC/d4T/NVP) are scarce. OBJECTIVE: To analyse 6861 patients in a large observational cohort from 21 Médecins Sans Frontieres (MSF) HIV/AIDS programmes taking 3TC/d4T/NVP, with subcohort analyses of patients at 12 and 18 months of treatment. METHODS: Survival was analysed using Kaplan-Meier method and factors associated with progression to death with Cox proportional hazard ratio. RESULTS: Median baseline CD4 cell count at initiating of FDC was 89 cells/microl [interquartile range (IQR), 33-158]. The median follow-up time was 4.1 months (IQR, 1.9-7.3). The incidence rate of death during follow-up was 14.2/100 person-years [95% confidence interval (CI), 13.8-14.5]. Estimates of survival (excluding those lost to follow-up) were 0.93 (95% CI, 92-94) at 6 months (n = 2,231) and 0.90 (95% CI, 89-91) at 12 months (n = 472). Using a Cox model, the following factors were associated with death: male gender, symptomatic infection, body mass index < 18 kg/m and CD4 cell count 15-50 cells/microl or < 15 cells/microl. Subcohort analysis of 655 patients after 1 year of follow-up (M12 FDC cohort) revealed that 77% remained on HAART, 91% of these still on the FDC regimen; 5% discontinued the FDC because of drug intolerance. At 18 months, 77% of the patients remained on HAART. CONCLUSIONS: Positive outcomes for d4T/3TC/NVP are reported for up to 18 months in terms of efficacy and safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M. A., Smith, D., Robinson, P., Hall, D., et al. (1998) · JAMA · doi:10.1001/jama.279.12.930 · Cited by 756
Cited by
Dabis, F. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.044248 · Cited by 306
Gupta, A., Nadkarni, G., Yang, W.-T., Chandrasekhar, A., Gupte, N., Bisson, G. P., Hosseinipour, M., & Gummadi, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028691 · Cited by 254
Chung, M. H., Richardson, B. A., Tapia, K., Benki-Nugent, S., Kiarie, J. N., Simoni, J. M., Overbaugh, J., Attwa, M., & John-Stewart, G. C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000422 · Cited by 109
“Among individuals with imperfect adherence, the choice of antiretroviral regimens may impact the development of antiretroviral resistance. In resource-limited settings, most antiretroviral regimens contain non-nucleoside reverse transcriptase inhibitors (NNRTI)”
HIV treatment and care in resource‐constrained environments: challenges for the next decade
Eholié, S., Aoussi, F. E., Ouattara, I. S., Bissagnéné, E., & Anglaret, X. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.2.17334 · Cited by 42
Metadata
- Authors
- Calmy, A., Pinoges, L., Szumilin, E., Zachariah, R., Ford, N., & Ferradini, L.
- Venue
- AIDS
- Published
- 2006-05-12
- Volume
- 20
- Issue
- 8
- Pages
- 1163-1169
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2065293221
- Cited by
- 163
- References
- 1
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. https://app.cochat.ai/papers/10.1097/01.aids.0000226957.79847.d6
- The paper
- Calmy, A., Pinoges, L., Szumilin, E., Zachariah, R., Ford, N., & Ferradini, L. (2006). Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. https://doi.org/10.1097/01.aids.0000226957.79847.d6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.